Could a leukemia drug slow Alzheimer's? small study tests safety

This study tested a low dose of nilotinib, a drug used for leukemia, in 37 people with mild to moderate Alzheimer's disease. The goal was to see if the drug is safe and can reach the brain to affect proteins linked to Alzheimer's, like tau and amyloid. Participants took the drug or a placebo daily for a period, and researchers monitored side effects and changes in spinal fluid and brain scans. The study was small and focused on safety, so it does not prove the drug works for Alzheimer's.